SCHEMBL18436896

SCHEMBL18436896

Cc1nc2c(I)cccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.53
ALDH1A1 P00352 1/20 0.43
TYMS P04818 1/20 0.41
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
ADRB2 P07550 1/20 0.39
HTT P42858 1/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MGAM O43451 4/20 0.38
GAA P10253 4/20 0.38
SI P14410 4/20 0.38
MGAM2 Q2M2H8 4/20 0.38
NOS1 P29475 1/20 0.37
DHODH Q02127 1/20 0.36
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20936149 0.79 PARP1 (0.56) PARP1ALDH1A1DRD2DRD4DRD3
SCHEMBL353891 0.79 PARP1 (0.56) PARP1MGAMGAASIMGAM2
Bromide SCHEMBL5318091 0.78 PARP1 (0.55) PARP1MGAMGAASIMGAM2
SCHEMBL17276083 0.76 NUDT1 (0.51) ALDH1A1TYMSGAA
SCHEMBL1701339 0.76 PARP1 (0.53) PARP1ALDH1A1DRD2DRD4DRD3
SCHEMBL29438962 0.76 PARP1 (0.53) PARP1ALDH1A1DRD2DRD4DRD3
SCHEMBL1013125 0.76 PARP1 (0.59) PARP1ALDH1A1DRD2DRD4DRD3
SCHEMBL1902643 0.76 PARP1 (0.53) PARP1ALDH1A1DRD2DRD4DRD3
SCHEMBL3884588 0.76 PARP1 (0.59) PARP1ALDH1A1ADRB2HTTKDM4E
SCHEMBL8265192 0.76 PARP1 (0.59) PARP1ALDH1A1HTTMGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023098699-A1 COMPOUNDS AND THEIR USES AS CD38 INHIBITORS NANJING IMMUNOPHAGE BIOTECH CO., LTD (CN) 2023-06-08 WO disclosed
EP-2513113-B1 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS IDENIX PHARMACEUTICALS LLC (US) 2018-08-01 EP disclosed
EP-3124482-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-02-01 EP disclosed